Ketamine inhibits nitric oxide synthase in lipopolysaccharide-treated rat alveolar macrophages

被引:47
作者
Li, CY
Chou, TC
Wong, CS
Ho, ST
Wu, CC
Yen, MH
Ding, YA
机构
[1] NATL DEF MED CTR,TRI SERV GEN HOSP,DEPT MED RES,TAIPEI,TAIWAN
[2] NATL DEF MED CTR,TRI SERV GEN HOSP,DEPT PHARMACOL,TAIPEI,TAIWAN
[3] NATL DEF MED CTR,TRI SERV GEN HOSP,DEPT MED,TAIPEI,TAIWAN
[4] NATL DEF MED CTR,TRI SERV GEN HOSP,GRAD INST MED SCI,TAIPEI,TAIWAN
来源
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE | 1997年 / 44卷 / 09期
关键词
D O I
10.1007/BF03011971
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose: To evaluate the effects of ketamine on the activity and protein expression of inducible nitric oxide synthase (iNOS) induced by lipopolysaccharide (LPS) in rat alveolar macrophages. Methods: Pulmonary alveolar macrophages isolated from Wistar-Kyoto rats were used. After incubation of macrophages with ketamine (1, 10, or 100 mu M) and LPS (1 mu g.ml(-1)) for 24 hr, the cell-free medium was removed for measuring the nitrite and tumour necrosis factor-alpha (TNF-alpha) levels by Griess reaction and ELISA kit, respectively. The harvested macrophages were also used to determine the activity of iNOS by using the conversion of [H-3]-L-arginine to [H-3]-L-citruliine method. In addition, the protein expression of iNOS was detected by Western blot analysis. Results: In rat alveolar macrophages, (1) ketamine (1 to 100 mu M) caused a dose-dependent suppression of the production of nitrite and TNF-alpha induced by LPS and (ii) ketamine (100 mu M) inhibited the activity (46.5 +/- 4.8%, P < 0.05) and protein expression (35 +/- 11%, P < 0.05) of iNOS in response to LPS. Conclusion: These results show that ketamine inhibits the activity and expression of iNOS in LPS-activated alveolar macrophages, which may be associated with the reduction of the release of TNF-alpha following LPS treatment.
引用
收藏
页码:989 / 995
页数:7
相关论文
共 31 条
[1]   Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium [J].
Denlinger, LC ;
Fisette, PL ;
Garis, KA ;
Kwon, G ;
VazquezTorres, A ;
Simon, AD ;
Nguyen, B ;
Proctor, RA ;
Bertics, PJ ;
Corbett, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) :337-342
[2]  
DING AH, 1988, J IMMUNOL, V141, P2407
[3]   ISOFORMS OF NITRIC-OXIDE SYNTHASE - CHARACTERIZATION AND PURIFICATION FROM DIFFERENT CELL-TYPES [J].
FORSTERMANN, U ;
SCHMIDT, HHHW ;
POLLOCK, JS ;
SHENG, H ;
MITCHELL, JA ;
WARNER, TD ;
NAKANE, M ;
MURAD, F .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (10) :1849-1857
[4]   KETAMINE INHIBITS GLUTAMATE-STIMULATED, N-METHYL-D-ASPARTATE-STIMULATED, AND QUISQUALATE-STIMULATED CGMP PRODUCTION IN CULTURED CEREBRAL NEURONS [J].
GONZALES, JM ;
LOEB, AL ;
REICHARD, PS ;
IRVINE, S .
ANESTHESIOLOGY, 1995, 82 (01) :205-213
[5]  
GROSS SS, 1992, J BIOL CHEM, V267, P25722
[6]   EFFECTS OF CALCIUM-CHANNEL ANTAGONISTS ON THE INDUCTION OF NITRIC-OXIDE SYNTHASE IN CULTURED-CELLS BY IMMUNOSTIMULANTS [J].
HATTORI, Y ;
KASAI, K ;
SO, SB ;
HATTORI, S ;
BANBA, N ;
SHIMODA, SI .
LIFE SCIENCES, 1995, 57 (20) :1833-1840
[7]   Ketamine antagonizes nitric oxide release from cerebral cortex after middle cerebral artery ligation in rats [J].
Lin, SZ ;
Chiou, AL ;
Wang, Y .
STROKE, 1996, 27 (04) :747-752
[8]  
Lo CJ, 1996, ARCH SURG-CHICAGO, V131, P44
[9]  
MONCADA S, 1991, PHARMACOL REV, V43, P109
[10]   ROLE OF NITRIC-OXIDE SYNTHESIS IN MACROPHAGE ANTIMICROBIAL ACTIVITY [J].
NATHAN, CF ;
HIBBS, JB .
CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (01) :65-70